Abstract:This study was undertaken to address the effects of fetal mesencephalic tissue transplantation on the serotonin system in a rat model of Parkinson's disease (PD) while also investigating the usefulness of 4-[18 F]-ADAM (a serotonin transporter imaging agent) coupled with micro-PET for imaging serotonin transporters (SERTs). A PD model was induced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the right medial forebrain bundle of the nigrostriatal pathway, while cell transplantation was performed vi… Show more
“…In the rat striatum, DAT concentration is several folds higher than the concentration of SERT, and in normal healthy rat, striatal tissue binding of [ 123 I]β-CIT can be considered to be mediated mainly by DAT [30]. Even though SERT binding activity is decreased in the rat 6-OHDA model [32], there may still be a change in the proportion of striatal DAT versus SERT binding of [ 123 I]β-CIT. In a recent PET study, Sossi et al [33] observed changes in the non-specific background signal from [ 11 C]-methylphenidate (DAT tracer) in the striatum of unilaterally 6-OHDA-lesioned rats.…”
Background6-Hydroxydopamine (6-OHDA) is widely used in pre-clinical animal studies to induce degeneration of midbrain dopamine neurons to create animal models of Parkinson's disease. The aim of our study was to evaluate the potential of combined single-photon emission computed tomography/computed tomography (SPECT/CT) for the detection of differences in 6-OHDA-induced partial lesions in a dose- and time-dependent manner using the dopamine transporter (DAT) ligand 2β-carbomethoxy-3β-(4-[123I]iodophenyl)tropane ([123I]β-CIT).MethodsRats were unilaterally lesioned with intrastriatal injections of 8 or 2 × 10 μg 6-OHDA. At 2 or 4 weeks post-lesion, 40 to 50 MBq [123I]β-CIT was administered intravenously and rats were imaged with small-animal SPECT/CT under isoflurane anesthesia. The striatum was delineated and mean striatal activity in the lesioned side was compared to the intact side. After the [123I]β-CIT SPECT/CT scan, the rats were tested for amphetamine-induced rotation asymmetry, and their brains were immunohistochemically stained for DAT and tyrosine hydroxylase (TH). The fiber density of DAT- and TH-stained striata was estimated, and TH-immunoreactive cells in the rat substantia nigra pars compacta (SNpc) were stereologically counted.ResultsThe striatal uptake of [123I]β-CIT differed significantly between the lesion groups and the results were highly correlated to both striatal DAT- and TH-immunoreactive fiber densities and to TH-immunoreactive cell numbers in the rat SNpc. No clear progression of the lesion could be seen.Conclusions[123I]β-CIT SPECT/CT is a valuable tool in predicting the condition of the rat midbrain dopaminergic pathway in the unilateral partial 6-OHDA lesion model of Parkinson's disease and it offers many advantages, allowing repeated non-invasive analysis of living animals.
“…In the rat striatum, DAT concentration is several folds higher than the concentration of SERT, and in normal healthy rat, striatal tissue binding of [ 123 I]β-CIT can be considered to be mediated mainly by DAT [30]. Even though SERT binding activity is decreased in the rat 6-OHDA model [32], there may still be a change in the proportion of striatal DAT versus SERT binding of [ 123 I]β-CIT. In a recent PET study, Sossi et al [33] observed changes in the non-specific background signal from [ 11 C]-methylphenidate (DAT tracer) in the striatum of unilaterally 6-OHDA-lesioned rats.…”
Background6-Hydroxydopamine (6-OHDA) is widely used in pre-clinical animal studies to induce degeneration of midbrain dopamine neurons to create animal models of Parkinson's disease. The aim of our study was to evaluate the potential of combined single-photon emission computed tomography/computed tomography (SPECT/CT) for the detection of differences in 6-OHDA-induced partial lesions in a dose- and time-dependent manner using the dopamine transporter (DAT) ligand 2β-carbomethoxy-3β-(4-[123I]iodophenyl)tropane ([123I]β-CIT).MethodsRats were unilaterally lesioned with intrastriatal injections of 8 or 2 × 10 μg 6-OHDA. At 2 or 4 weeks post-lesion, 40 to 50 MBq [123I]β-CIT was administered intravenously and rats were imaged with small-animal SPECT/CT under isoflurane anesthesia. The striatum was delineated and mean striatal activity in the lesioned side was compared to the intact side. After the [123I]β-CIT SPECT/CT scan, the rats were tested for amphetamine-induced rotation asymmetry, and their brains were immunohistochemically stained for DAT and tyrosine hydroxylase (TH). The fiber density of DAT- and TH-stained striata was estimated, and TH-immunoreactive cells in the rat substantia nigra pars compacta (SNpc) were stereologically counted.ResultsThe striatal uptake of [123I]β-CIT differed significantly between the lesion groups and the results were highly correlated to both striatal DAT- and TH-immunoreactive fiber densities and to TH-immunoreactive cell numbers in the rat SNpc. No clear progression of the lesion could be seen.Conclusions[123I]β-CIT SPECT/CT is a valuable tool in predicting the condition of the rat midbrain dopaminergic pathway in the unilateral partial 6-OHDA lesion model of Parkinson's disease and it offers many advantages, allowing repeated non-invasive analysis of living animals.
“…Of 24 Parkinsonian rats (PD group) initially scanned by PET, six received a graft consisting of ventral mesencephalic tissue (2 µl) and HBSS (2 µl; VM group), six received a graft consisting of mesencephalic tissue (2 µl) and OECs (2 µl; 2 × 10 5 cells; VM–OECs group), and six received a graft consisting of OECs (2 µl; 2 × 10 5 cells; OECs group). The mesencephalic tissue was dissected from embryonic day 14 (E14) fetal brains (Takeuchi et al ., ), with the dissection area selected according to the protocols of Dunnet and Björklund (Dunnett and Björklund, ) with minor modifications (Weng et al ., ). The dissected tissue blocks contained the ventral mesencephalon and part of the ventral pontine raphe, which contain dopaminergic and serotonergic cell bodies, respectively.…”
Section: Methodsmentioning
confidence: 97%
“…Considering the partial volume effect between brain regions on voxel‐based PET images (Lehnert et al ., ), the VOIs were bordering within the brain structures. The SUR was expressed as (striatum ‐ cerebellum) / cerebellum, the cerebellum was defined as reference region (Ma et al ., ; Li et al ., ; Weng et al ., ).…”
Section: Methodsmentioning
confidence: 97%
“…The tissue blocks were maintained in Hank's Buffered Salt Solution (HBSS, Thermo Scientific) during the transplantation procedure. The ventral mesencephalic tissue (Zhou et al ., ; Weng et al ., ) was cut into small pieces and transplanted to restore the nigrostriatal projections to the ipsilateral side of the brain. A glass micropipette was used to inject (in the following order) mesencephalic tissue (4 µl; about 0.5×10 5 cells), air (1 µl), and KA (4 µl; 0.25 µg/µl) to form a bridging track from the substantia nigra to the striatum (0.98 mm anterior to the bregma, 0.25 mm lateral to the midline, 11.5 mm below the dura; at an angle of 60° from vertical) (Zhou et al ., ).…”
Section: Methodsmentioning
confidence: 99%
“…4‐[ 18 F]–ADAM (14.8 – 18.5 MBq; 0.4 – 0.5 mCi) was injected into the tail veins of normal, PD, and grafted PD (but not including OECs grafted) rats for PET imaging. Micro‐PET image acquisition was performed as previously reported (Ma et al ., ; Li et al ., ; Weng et al ., ) with minor modifications. Briefly, rats were anesthetized by passive inhalation of a mixture of isoflurane/oxygen (5% isoflurane for induction and 2% for maintenance).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.